The News London 365
  • Breaking News
  • Lifestyle
  • Coronavirus
  • Food
  • Politics
  • Sport
Sunday, June 26, 2022
London
+10°C
Privacy Policy
Copyright
Contact us
No Result
View All Result
  • Breaking News
  • Lifestyle
  • Coronavirus
  • Food
  • Politics
  • Sport
No Result
View All Result
The News London 365
No Result
View All Result
Home Coronavirus

Exclusive-AstraZeneca COVID-19 vaccine shipped to Canada, Mexico before adequate plant inspections By Reuters

The News London 365 by The News London 365
July 29, 2021
in Coronavirus
0
Vaccinations slowing spread of COVID-19 cases in Spain

2/2

© Reuters. FILE PHOTO: Boxes of AstraZeneca’s vaccine against the coronavirus disease (COVID-19) are seen at a walk-in vaccination centre in Algiers, Algeria June 6, 2021. Picture taken June 6, 2021. REUTERS/Ramzi Boudina/File Photo

2/2

By Allison Martell, Carl O’Donnell and Cassandra Garrison

(Reuters) -Canada and Mexico imported millions of doses of AstraZeneca (NASDAQ:)’s COVID-19 vaccine and offered them to the public without health officials properly inspecting the operations of the U.S. manufacturer, according to inspection records and the regulators involved.

The Baltimore plant belonging to Emergent BioSolutions Inc was producing vaccines for both AstraZeneca Plc and Johnson & Johnson (NYSE:) under a $628 million U.S. government contract.

In late March, under pressure to help other nations access COVID-19 vaccines, the Biden administration released 1.5 million AstraZeneca doses to Canada, and 2.5 million to Mexico.

European regulators had certified Emergent’s factory as complying with “good manufacturing practices,” and on that basis both Canada and Mexico began using the vaccine, regulators in both countries told Reuters.

But the European Medicines Agency (EMA) told Reuters that the certification was based on a remote inspection that focused on a part of the facility that was not actually producing the AstraZeneca shots – a fact that has not been previously reported.

The U.S. Food and Drug Administration halted production at the factory three weeks later, after J&J’s vaccine was found to be contaminated with material used in the AstraZeneca shots.

FDA inspectors later documented unsanitary conditions and poorly-trained staff at the plant, which had been rapidly overhauled to make vaccines during the pandemic. Production had remained halted, with tens of millions of doses of both vaccines in regulatory limbo.

Emergent said on Thursday the FDA was allowing it to resume production of J&J doses at the Baltimore plant after completing additional regulatory reviews.

No reports of illness have been linked to vaccines manufactured by Emergent, and regulators have not alleged that contaminated vaccines were given to anyone. Emergent said there has been no evidence of contamination in the AstraZeneca shots produced at its site.

But details of the flawed approval process show blind spots that can develop when national regulators share responsibility for overseeing a complex global pharmaceutical industry. Those were only exacerbated given the urgency of the pandemic.

“It’s a risk, because who knows what the standards are that are being applied?” said Joel Lexchin, a Canadian professor and expert in drug regulation. Health Canada typically relies heavily on foreign regulators, he said. “It’s a gap that exists outside of crisis times.”

Emergent said in a statement that it “has worked with health officials around the world to ensure any vaccine drug substance we manufactured meets strict safety and quality requirements before being released.”

AstraZeneca said vaccines manufactured by Emergent were subject to more than 40 tests to meet its requirements for safety, purity and quality, and that its manufacturing standards “are rigorously assessed and independently verified by regulators.”

Health Canada told Reuters it is confident the vaccines it received were safe, pointing in part to AstraZeneca’s quality control systems. Mexico health regulator COFEPRIS said it remains “confident that the approval process was carried out with all the necessary rigor.”

Canada signed deals to formally recognize some other regulators’ certifications as early as 2003, and the United States and Europe reached similar deals in 2019.

A EUROPEAN INSPECTION

Early in the vaccine rollout, the European Union was due to receive doses of the J&J vaccine made by Emergent. In early February, Italian officials conducted a remote inspection of the plant that only focused on areas where J&J production was taking place “and not the AstraZeneca vaccine, which was not manufactured at Emergent for the EU market,” EMA said in a statement.

Health Canada said it assumed both products would be made to the same standard. “The quality systems assessed by the EMA for this product would be applicable to all similar products made at this site,” it said in a statement.

This is the wrong approach, according to University of Ottawa professor Amir Attaran, who studies drug policy, including Health Canada’s reliance on foreign regulators.

“It’s precisely because they were similar (products) that cross contamination is a risk,” he said. Canada was “out on a limb” approving AstraZeneca doses from the facility before the FDA, he said.

Health Canada said it reviewed test results and quality control steps for every vaccine lot sent to Canada.

Initially, Mexico’s COFEPRIS told Reuters the FDA was responsible for certifying U.S. operations, but later confirmed that the factory had been certified by European regulators.

When Reuters shared the European regulators’ statement that it had not assessed AstraZeneca production specifically, COFEPRIS said it would review the file, but remained confident in the approval process.

The Mexican regulator said vaccines went through quality control systems at Emergent, and twice more during the vial filling process handled by another contract manufacturer.

“When evaluating vaccines, the product and its entire production process are considered and examined,” it said in a statement.

Emergent’s contract with the U.S. government is the focus of a Congressional investigation, which unearthed documents that highlight early concerns about the Baltimore plant.

Soon after the Trump administration announced Emergent’s contract last summer, its own vaccine officials visited the plant and wrote a report flagging inadequate staffing and training. The report warned of the need to strengthen quality oversight, a process that would “require significant resources and commitment.”

The FDA, following a February 2021 visit to the plant, noted in a June memo that Emergent staff turnover was high and record-keeping inadequate. While European regulators said they were aware of that visit, Health Canada said it did not learn about it until last month.

An FDA spokesperson said the agency works closely with international partners, and that it notified various health authorities of its findings after its April 2021 inspection of the Emergent facility.

Emergent said it is still working with the FDA to release more of the already produced COVID-19 vaccine batches.

“We have manufactured tens of millions of doses that could be used to help vaccinate people around the world as the pandemic shows no signs of slowing down,” the company said.

Previous Post

Tunisia’s political crisis poses existential test for Islamist party By Reuters

Next Post

Jodie Whittaker confirms departure from Doctor Who

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECENT NEWS

Canada to send 8 armoured vehicles to Ukraine amid heavy weapons push

Canada to send 8 armoured vehicles to Ukraine amid heavy weapons push

June 26, 2022
My OCD makes me think I’m going to kill someone or be killed

My OCD makes me think I’m going to kill someone or be killed

June 26, 2022
Embracing quiet moments can change your life for the better – here’s how

Embracing quiet moments can change your life for the better – here’s how

June 26, 2022
The Big Happiness Interview: Sonia Choquette on why your intuition is your superpower

The Big Happiness Interview: Sonia Choquette on why your intuition is your superpower

June 26, 2022
I was told to wear a black bra to cure my breast cancer – these kinds of suggestions are dangerous

I was told to wear a black bra to cure my breast cancer – these kinds of suggestions are dangerous

June 26, 2022
£33m cash boost would ‘give us truly global appeal’

£33m cash boost would ‘give us truly global appeal’

June 26, 2022

Categories

Breaking News Coronavirus Daily Devotionals Food Health and Science Lifestyle Politics Sport What's On

Recent News

Canada to send 8 armoured vehicles to Ukraine amid heavy weapons push

Canada to send 8 armoured vehicles to Ukraine amid heavy weapons push

June 26, 2022
The News London 365

  • Privacy Policy
  • Copyright
  • Contact us
No Result
View All Result
  • Breaking News
  • Lifestyle
  • Coronavirus
  • Food
  • Politics
  • Sport

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT